company background image
2633 logo

Jacobson Pharma SEHK:2633 Stok Raporu

Son Fiyat

HK$0.64

Piyasa Değeri

HK$1.3b

7D

-1.5%

1Y

-1.5%

Güncellenmiş

04 Nov, 2024

Veri

Şirket Finansalları

Jacobson Pharma Corporation Limited

SEHK:2633 Stok Raporu

Piyasa değeri: HK$1.3b

2633 Stoklara Genel Bakış

Jacobson Pharma Corporation Limited, iştirakleri aracılığıyla Hong Kong, Çin Anakarası, Makao, Singapur'da ve uluslararası alanda jenerik ilaçlar ve markalı sağlık ürünleri geliştirmekte, üretmekte, pazarlamakta ve satmaktadır.

Jacobson Pharma Corporation Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Jacobson Pharma
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıHK$0.64
52 Haftanın En Yüksek SeviyesiHK$0.68
52 Haftanın En Düşük SeviyesiHK$0.54
Beta0.40
11 Aylık Değişim1.59%
3 Aylık Değişim10.34%
1 Yıllık Değişim-1.54%
33 Yıllık Değişim18.52%
5 Yıllık Değişim-54.93%
Halka arzdan bu yana değişim-61.90%

Son Haberler & Güncellemeler

Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now

Aug 21
Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now

Recent updates

Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now

Aug 21
Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now

Jacobson Pharma's (HKG:2633) Profits May Not Reveal Underlying Issues

Dec 21
Jacobson Pharma's (HKG:2633) Profits May Not Reveal Underlying Issues

Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025

Nov 27
Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025

These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well

Jun 20
These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well

Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's

Nov 28
Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's

Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.0268

Sep 25
Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.0268

Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?

Sep 16
Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?

Jacobson Pharma's (HKG:2633) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 28
Jacobson Pharma's (HKG:2633) Shareholders Will Receive A Bigger Dividend Than Last Year

Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's

Jul 14
Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's

Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?

Feb 09
Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?

Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.012

Nov 29
Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.012

Jacobson Pharma (HKG:2633) Is Reducing Its Dividend To HK$0.015

Sep 24
Jacobson Pharma (HKG:2633) Is Reducing Its Dividend To HK$0.015

Here's Why It's Unlikely That Jacobson Pharma Corporation Limited's (HKG:2633) CEO Will See A Pay Rise This Year

Sep 16
Here's Why It's Unlikely That Jacobson Pharma Corporation Limited's (HKG:2633) CEO Will See A Pay Rise This Year

Kwing Tong Lam Is The Independent Non-Executive Director of Jacobson Pharma Corporation Limited (HKG:2633) And They Just Picked Up 28% More Shares

Feb 03
Kwing Tong Lam Is The Independent Non-Executive Director of Jacobson Pharma Corporation Limited (HKG:2633) And They Just Picked Up 28% More Shares

A Look At The Fair Value Of Jacobson Pharma Corporation Limited (HKG:2633)

Jan 24
A Look At The Fair Value Of Jacobson Pharma Corporation Limited (HKG:2633)

Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden

Jan 11
Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden

Does Jacobson Pharma's (HKG:2633) CEO Salary Compare Well With The Performance Of The Company?

Dec 27
Does Jacobson Pharma's (HKG:2633) CEO Salary Compare Well With The Performance Of The Company?

Is It Smart To Buy Jacobson Pharma Corporation Limited (HKG:2633) Before It Goes Ex-Dividend?

Dec 12
Is It Smart To Buy Jacobson Pharma Corporation Limited (HKG:2633) Before It Goes Ex-Dividend?

Reflecting on Jacobson Pharma's (HKG:2633) Share Price Returns Over The Last Three Years

Dec 03
Reflecting on Jacobson Pharma's (HKG:2633) Share Price Returns Over The Last Three Years

Hissedar Getirileri

2633HK PharmaceuticalsHK Pazar
7D-1.5%-7.2%-1.0%
1Y-1.5%-2.9%15.0%

Getiri vs. Endüstri: 2633 exceeded the Hong Kong Pharmaceuticals industry which returned -2.9% over the past year.

Getiri vs Piyasa: 2633 underperformed the Hong Kong Market which returned 15% over the past year.

Fiyat Oynaklığı

Is 2633's price volatile compared to industry and market?
2633 volatility
2633 Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement9.0%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.3%

İstikrarlı Hisse Senedi Fiyatı: 2633 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Zaman İçindeki Volatilite: 2633's weekly volatility (4%) has been stable over the past year.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
20161,723Derek Sumwww.jacobsonpharma.com

Jacobson Pharma Corporation Limited, iştirakleri aracılığıyla Hong Kong, Çin Anakarası, Makao, Singapur'da ve uluslararası alanda jenerik ilaçlar ve markalı sağlık ürünleri geliştirmekte, üretmekte, pazarlamakta ve satmaktadır. Şirket, gastrointestinal bozukluklar, kardiyovasküler durumlar, enflamatuar ve otoimmün hastalıklar, multipl miyelom tedavisi, onkoloji, meme kanseri tedavisi, merkezi sinir sistemi, solunum, oral antidiyabetikler, kas-iskelet, genito-üriner, anti-enfektifler, endokrin ve metabolik, dermatolojik ve anti-alerjikler dahil olmak üzere çeşitli terapötik kategoriler için jenerik ilaçlar sunmaktadır. Ayrıca markalı ilaçlar; sağlık ve zindelik ürünleri ve tescilli Çin ilaçları; hazine hizmetleri ve yönetim hizmetleri de sunmaktadır.

Jacobson Pharma Corporation Limited Temel Bilgiler Özeti

Jacobson Pharma'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
2633 temel i̇stati̇sti̇kler
Piyasa değeriHK$1.27b
Kazançlar(TTM)HK$186.36m
Gelir(TTM)HK$1.47b

6.8x

F/K Oranı

0.9x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
2633 gelir tablosu (TTM)
GelirHK$1.47b
Gelir MaliyetiHK$847.32m
Brüt KârHK$620.48m
Diğer GiderlerHK$434.12m
KazançlarHK$186.36m

Son Raporlanan Kazançlar

Mar 31, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)0.094
Brüt Marj42.27%
Net Kâr Marjı12.70%
Borç/Özkaynak Oranı29.4%

2633 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

8.6%

Mevcut Temettü Verimi

57%

Ödeme Oranı